AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 152 institutions reported holding it in 13F filings for Q2 2026, worth $909.0M in total; no superinvestor holds it.
Holders of 5% or more of ABCL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of AbCellera Biologics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13G/A | 10.80%33.0M shares | – | Feb 14, 20243 filings | May 7, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on AbCellera Biologics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 7, 20264:10 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 10.80%33.0M shares | – | Apr 30, 2026 | SEC |
| Nov 14, 2024 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Oct 9, 202410:20 AM ET | Baillie Gifford & Co | 13G/A | 4.40%12.9M shares | –Below 5% | Sep 30, 2024 | SEC |
| Feb 14, 2024 | Baker Bros. Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Hansen Carl L. G. | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2024 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
| Apr 24, 2023 | Thiel Peter | 13D/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Hansen Carl L. G. | 13G/AOld format | – | – | – | SEC |
| Jan 18, 2023 | Baillie Gifford & Co | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | DCVC Bio, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Capital World Investors | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Hansen Carl L. G. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Hansen Carl L. G. | 13GOld format | – | New | – | SEC |
| Feb 9, 2021 | DCVC Bio, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell AbCellera Biologics Inc. shares.
No Form 144 notices for AbCellera Biologics Inc. are on file.